Techne Corporation synthesizes proteins, antibodies and other tools are used by scientists within the medical community to develop methods of diagnosing and treating diseases. The company's hematology division also develops instruments that can be used to test the accuracy of blood testing equipment. Techne's largest customers include pharmaceutical companies universities and government research centers, and the company's research is guided by both proposals from its own scientists.

Techne Corporation has been able to capitalize on the growth in the health care sector during the past two decades. Techne also faces competition from larger companies such as Becton, Dickinson and Company (BDX) and Millipore (MIL), whose primary business is not in the biotechnology industry but who do have divisions actively researching areas concerning biotechnology.

(Read more at Wikinvest )